BRAF and Papillary Craniopharyngioma: Calvanese et al. reported two cases of adult patients with papillary craniopharyngioma who underwent anti-BRAF/MEK combined therapy as adjuvant (case 1) or neoadjuvant (case 2) treatment [192].